Cancer and depression drugs could be ‘repurposed’ to cure dementia, study finds
Results in mice could now pave the way for clinical trials in humans
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A new study has sparked fresh hope for dementia sufferers after two existing drugs were found to help reduce the impact of degenerative brain diseases in mice.
Researchers found drugs originally designed to treat depression and cancer could be “repurposed”, reducing brain shrinkage and restoring protein production.
The study, published in Brain: a journal of neurology, could now pave the way for a clinical trial in humans to see if the results could be replicated.
“The two drugs were markedly neuroprotective in both prion-diseased and FTD mice at clinically relevant doses over a sustained treatment period,” the authors wrote.
“These drugs therefore represent an important step forward in the pursuit of disease-modifying treatments for Alzheimer’s and related disorders.”
Dr Doug Brown, Alzheimer's Society’s research and development director said the charity will be funding researchers to test the drugs in models of Alzheimer’s.
“We’re excited by the potential of these findings. They show that a treatment approach originally discovered while researching prion disease might also work to prevent the death of brain cells in some forms of dementia,” he said.
“This research is at a very early stage and has not yet been tested in people - but as one of the drugs is already available as a treatment for depression, the time taken to get from the lab to the pharmacy could be dramatically reduced.”
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments